|
KMO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41460000000027E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30739999999008E-05 |
| Normal-vs-Stage2 |
2.25149999999452E-05 |
| Normal-vs-Stage3 |
8.07970000000768E-05 |
| Normal-vs-Stage4 |
6.07870000000066E-05 |
| Stage1-vs-Stage2 |
9.285600E-01 |
| Stage1-vs-Stage3 |
2.731000E-01 |
| Stage1-vs-Stage4 |
7.769600E-01 |
| Stage2-vs-Stage3 |
3.104800E-01 |
| Stage2-vs-Stage4 |
7.356600E-01 |
| Stage3-vs-Stage4 |
7.094600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.04410000000022E-05 |
| Normal-vs-AfricanAmerican |
1.56136999999168E-05 |
| Normal-vs-Asian |
3.57589999999686E-05 |
| Caucasian-vs-AfricanAmerican |
1.899120E-03 |
| Caucasian-vs-Asian |
6.694000E-01 |
| AfricanAmerican-vs-Asian |
5.835400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54140000000669E-05 |
| Normal-vs-Female |
2.25689999999723E-05 |
| Male-vs-Female |
5.951400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.33060000000207E-05 |
| Normal-vs-Extreme_Weight |
1.95268999999554E-05 |
| Normal-vs-Obese |
4.4916000000006E-05 |
| Normal-vs-Extreme_Obese |
3.12540000002581E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.417600E-01 |
| Normal_Weight-vs-Obese |
9.184600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.163700E-02 |
| Extreme_Weight-vs-Obese |
2.321600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.535900E-03 |
| Obese-vs-Extreme_Obese |
6.819500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.51009999999263E-06 |
| Normal-vs-Age(41-60Yrs) |
3.55180000000122E-05 |
| Normal-vs-Age(61-80Yrs) |
3.5200000000013E-05 |
| Normal-vs-Age(81-100Yrs) |
9.5649000000031E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.957600E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.175900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.609980E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.950600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.818000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.235800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.99438999999302E-05 |
| Normal-VS-Type2 PRCC |
8.0456000000062E-05 |
| Normal-VS-KIRP CIMP |
4.386600E-04 |
| Normal-VS-Unclassified PRCC |
2.39489999999121E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.753600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.147600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.290400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.869800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.100400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.163000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.88660000000263E-05 |
| Normal-vs-N1 |
1.044670E-04 |
| Normal-vs-N2 |
2.77059999997942E-06 |
| N0-vs-N1 |
5.350200E-01 |
| N0-vs-N2 |
1.760970E-04 |
| N1-vs-N2 |
2.030200E-02 |
|
|
